Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bruno

Showing results (211-220 of 302) with videos related to

Pageof 31
Sort By:
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|March 3, 2026
Cardiac surveillance in the era of Duvyzat: do we need to do more?Marika Pane, Anna Capasso, Chiara Arpaia, et al.
Plos One|June 26, 2019
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53Claudia Brogna, Giorgia Coratti, Marika Pane, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Neuromuscular Disorders : NMD|March 30, 2016
"Mitochondrial neuropathies": A survey from the large cohort of the Italian NetworkMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|February 27, 2016
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort studySonia Messina, Gian Luca Vita, Maria Sframeli, et al.
Annals of Clinical and Translational Neurology|August 20, 2025
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History ComparisonsCraig M McDonald, Michela Guglieri, Dragana Vučinić, et al.
Neuromuscular Disorders : NMD|June 8, 2021
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersenGiorgia Coratti, Marika Pane, Simona Lucibello, et al.
Frontiers in Neurology|August 28, 2020
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in <i>SCN4A</i> in a Large Cohort of Italian PatientsLorenzo Maggi, Raffaella Brugnoni, Eleonora Canioni, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Pageof 31

Showing results (211-220 of 302) with videos related to

Sort By:
Pageof 31
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|March 3, 2026
Cardiac surveillance in the era of Duvyzat: do we need to do more?Marika Pane, Anna Capasso, Chiara Arpaia, et al.
Plos One|June 26, 2019
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53Claudia Brogna, Giorgia Coratti, Marika Pane, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Neuromuscular Disorders : NMD|March 30, 2016
"Mitochondrial neuropathies": A survey from the large cohort of the Italian NetworkMichelangelo Mancuso, Daniele Orsucci, Corrado Angelini, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|February 27, 2016
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort studySonia Messina, Gian Luca Vita, Maria Sframeli, et al.
Annals of Clinical and Translational Neurology|August 20, 2025
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History ComparisonsCraig M McDonald, Michela Guglieri, Dragana Vučinić, et al.
Neuromuscular Disorders : NMD|June 8, 2021
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersenGiorgia Coratti, Marika Pane, Simona Lucibello, et al.
Frontiers in Neurology|August 28, 2020
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in <i>SCN4A</i> in a Large Cohort of Italian PatientsLorenzo Maggi, Raffaella Brugnoni, Eleonora Canioni, et al.
Eclinicalmedicine|December 17, 2024
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016Maria Carmela Pera, Giorgia Coratti, Marika Pane, et al.
Pageof 31